PACB
PACB
NASDAQ · Life Sciences Tools & Services

Pacific Biosciences Of Calif

$1.40
+0.06 (+4.48%)
As of Jun 21, 10:19 PM ET ·
Analyst Consensus
Buy
15
Analysts
High
Coverage
Buy 9 60%
Hold 5 33%
Sell 1 7%
Price Target
Analyst Price Target +3,250.0% upside
Low Target $34.06
Average Target $46.90
High Target $60.93
Current Price $1.40
Current
$1.40
Target
$46.90
$34.06 $46.90 avg $60.93
Scenario Analysis
Bear Case
$34.06
2,332.9%
Low target
Base Case
$46.90
+3,250.0%
Avg target
Bull Case
$60.93
+4,252.1%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$2.73
-48.7% from high
52-Week Low
$1.09
+28.4% from low
Target vs 52W High
$46.90
+1,617.9% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 34 85% $369.21 -21.3%
DHR
Danaher Corp
Strong Buy 30 90% $158.11 -11.7%
A
Agilent Technologies Inc
Strong Buy 28 79% $64.69 -48.9%
WAT
Waters Corp
Buy 28 57% $189.60 -46.9%
IQV
Iqvia Holdings Inc
Strong Buy 30 80% $82.96 -51.6%
ILMN
Illumina Inc
Buy 28 61% $169.36 +2.7%
WST
West Pharmaceutical Services
Strong Buy 22 82% $136.24 -59.5%
MTD
Mettler-Toledo International
Hold 20 50% $170.43 -85.3%